A study examined factors associated with multiple failures to biologic disease-modifying antirheumatic drugs (bDMARDs) among patients with rheumatoid arthritis (RA). They concluded that younger age and the presence of erosions were independent risk factors. “Nowadays, despite the increasing number of therapeutic tools available, the successful treatment of certain RA patients remains particularly challenging for clinicians,” … Continue reading Which Patients With Rheumatoid Arthritis Are More Likely to Experience Multiple Biologic Failures?
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed